I have been in two others, MHAN now TSGX and CYTR, that both did this, multiple dilution rounds, between 2009 and 2011 under $1. Sooner or later MSTX is likely to be a 5-10 bagger, only question is when. I think people worry about a possible R/S here since they have a history of it.
I am still wondering what happened to the other drug they were ready to do an NDA on 2 years ago, that they claimed had a billion dollar market, no news on it since they started pumping the current the one they are focused on now that they bought from CYTR.
Ambition with out knowledge is like ship in dry dock. Going nowhere fast!